Dopamine D₁ and D₅ receptors differentially regulate oxidative stress through paraoxonase 2 in kidney cells

References

• Hussain T, Lokhandwala MF. Renal dopamine receptors and hypertension. Exp Biol Med 2003;228:134–142.
   PubMed Web of Science ®Google Scholar
• Zeng C, Zhang M, Asico LD, Eisner GM, Jose PA. The dopaminergic system in hypertension. Clin Sci 2007;112:583–597.
   PubMed Web of Science ®Google Scholar
• Armando I, Villar VA, Jose PA. Dopamine and renal function and blood pressure regulation. Compr Physiol 2011;1:1075–1117.
   PubMed Web of Science ®Google Scholar
• Beaulieu JM, Gainetdinov RR. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 2011;63:182–217.
   PubMed Web of Science ®Google Scholar
• Asghar M, Tayebati SK, Lokhandwala MF, Hussain T. Potential dopamine-1 receptor stimulation in hypertension management. Curr Hypertens Rep 2011;13:294–302.
   PubMed Web of Science ®Google Scholar
• Harris RC. Abnormalities in renal dopamine signaling and hypertension: the role of GRK4. Curr Opin Nephrol Hypertens 2012;21:61–65.
   PubMed Web of Science ®Google Scholar
• Soares-da-Silva P, Pestana M, Ferreira A, Damasceno A, Polónia J, Cerqueira-Gomes M.Renal dopaminergic mechanisms in renal parenchymal diseases, hypertension, and heart failure. Clin Exp Hypertens 2000;22:251–268.
   PubMed Web of Science ®Google Scholar
• Carey RM. Theodore Cooper Lecture: Renal dopamine system: paracrine regulator of sodium homeostasis and blood pressure. Hypertension 2001;38:297–302.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Cuevas S, Asico LD, Escano C, Yang Y, Pascua AM, et al. Deficient dopamine D2 receptor function causes renal inflammation independently of high blood pressure. PLoS One 2012;7:e38745.
   Web of Science ®Google Scholar
• Li H, Armando I, Yu P, Escano C, Mueller SC, Asico L, et al. Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cells. J Clin Invest 2008;118:2180–2189.
   PubMed Web of Science ®Google Scholar
• Forman HJ, Torres M. Reactive oxygen species and cell signaling. Am J Respir Crit Care Med 2002;166:S4–S8.
   PubMed Web of Science ®Google Scholar
• Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 2010;48:749–762.
   PubMed Web of Science ®Google Scholar
• Ray PD, Huang BW, Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 2012;24:981–990.
   PubMed Web of Science ®Google Scholar
• Datla SR, Griendling KK. Reactive oxygen species, NADPH oxidases, and hypertension. Hypertension 2010;56:325–330.
   PubMed Web of Science ®Google Scholar
• Briones AM, Touyz RM. Oxidative stress and hypertension: current concepts. Curr Hypertens Rep 2010;12:135–142.
   PubMed Web of Science ®Google Scholar
• Wilcox CS. Asymmetric dimethylarginine and reactive oxygen species: Unwelcome twin visitors to the cardiovascular and kidney disease tables. Hypertension 2012;59:375–381.
   PubMed Web of Science ®Google Scholar
• Cuevas S, Villar VA, Jose PA, Armando I. Renal dopamine receptors, oxidative stress, and hypertension. Int J Mol Sci 2013;14:17553–17572.
   PubMed Web of Science ®Google Scholar
• Araujo M, Wilcox CS. Oxidative stress in hypertension: role of the kidney. Antioxid Redox Signal 2014;20:74–101.
   PubMed Web of Science ®Google Scholar
• Lassègue B, San Martin A, Griendling KK. Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ Res 2012;110:1364–1390.
   PubMed Web of Science ®Google Scholar
• Sedeek M, Nasrallah R, Touyz RM, Hébert RL. NADPH oxidases, reactive oxygen species, and the kidney: friend and foe. J Am Soc Nephrol 2013;24:1512–1518.
   PubMed Web of Science ®Google Scholar
• Wilcox CS. Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension? Am J Physiol Regul Integr Comp Physiol 2005;289:R913–R935.
   PubMed Web of Science ®Google Scholar
• Schiffrin EL. Antioxidants in hypertension and cardiovascular disease. Mol Interv 2010;10:354–362.
   PubMed Web of Science ®Google Scholar
• Fontayne A, Dang PM, Gougerot-Pocidalo MA, El-Benna J. Phosphorylation of p47phox sites by PKC alpha, beta II, delta, and zeta: effect on binding to p22phox and on NADPH oxidase activation. Biochemistry 2002;41:7743–7750.
   PubMed Web of Science ®Google Scholar
• Quinn MT, Gauss KA. Stucture and regulation of the neutrophil respiratory burst oxidase: comparison with nonphagocyte oxidase. J Leukoc Biol 2004;76:760–781.
   PubMed Web of Science ®Google Scholar
• Touyz RM, Chen X, Tabet F, Yao G, He G, Quinn MT, et al. Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circ Res 2002;90:1205–1213.
   PubMed Web of Science ®Google Scholar
• Vignais PV. The superoxide-generating NADPH oxidase: structural aspects and activation mechanism. Cell Mol Life Sci 2002;59:1428–1459.
   PubMed Web of Science ®Google Scholar
• Draganov DI, Teiber JF, Speelman A, Osawa Y, Sunahara R, La Du BN. Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities. J Lipid Res 2005;46:1239–1247.
   PubMed Web of Science ®Google Scholar
• Aviram M, Vaya J. Paraoxonase 1 activities, regulation, and interactions with atherosclerotic lesion. Curr Opin Lipidol 2013;24:339–344.
   PubMed Web of Science ®Google Scholar
• Martinelli N, Consoli L, Girelli D, Grison E, Corrocher R, Olivieri O. Paraoxonases: ancient substrate hunters and their evolving role in ischemic heart disease. Adv Clin Chem 2013;59:65–100.
   PubMed Web of Science ®Google Scholar
• Reddy ST, Wadleigh DJ, Grijalva V, Ng C, Hama S, Gangopadhyay A, et al. Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids. Arterioscler Thromb Vasc Biol 2001;21:542–547.
   PubMed Web of Science ®Google Scholar
• Précourt LP, Amre D, Denis MC, Lavoie JC, Delvin E, Seidman E, Levy E. The three-gene paraoxonase family: physiologic roles, actions and regulation. Atherosclerosis 2011;214:20–36.
   PubMed Web of Science ®Google Scholar
• Shiner M, Fuhrman B, Aviram M. A biphasic U-shape effect of cellular oxidative stress on the macrophage anti-oxidant paraoxonase 2 (PON2) enzymatic activity. Biochem Biophys Res Commun 2006;349:1094–1099.
   PubMed Web of Science ®Google Scholar
• Horke S, Witte I, Wilgenbus P, Krüger M, Strand D, Förstermann U. Paraoxonase-2 reduces oxidative stress in vascular cells and decreases endoplasmic reticulum stress-induced caspase activation. Circulation 2007;115:2055–2064.
   PubMed Web of Science ®Google Scholar
• Yang Y, Zhang Y, Cuevas S, Villar VA, Escano C, Asico LD, et al. Paraoxonase 2 decreases renal reactive oxygen species production, lowers blood pressure, and mediates dopamine D2 receptor-induced inhibition of NADPH oxidase. Free Radic Biol Med 2012;53:437–446.
   PubMed Web of Science ®Google Scholar
• Li PL, Zhang Y, Yi F. Lipid raft redox signaling platforms in endothelial dysfunction. Antioxid Redox Signal 2007;9:1457–1470.
   PubMed Web of Science ®Google Scholar
• Han W, Li H, Villar VA, Pascua AM, Dajani MI, Wang X, et al. Lipid rafts keep NADPH oxidase in the inactive state in human renal proximal tubule cells. Hypertension 2008;51:481–487.
   PubMed Web of Science ®Google Scholar
• Li PL, Zhang Y. Cross talk between ceramide and redox signaling: implications for endothelial dysfunction and renal disease. Handb Exp Pharmacol 2013;216:171–197.
   Google Scholar
• Burger D, Montezano AC, Nishigaki N, He Y, Carter A, Touyz RM. Endothelial microparticle formation by angiotensin II is mediated via Ang II receptor type I/NADPH oxidase/Rho kinase pathways targeted to lipid rafts. Arterioscler Thromb Vasc Biol 2011;31:1898–1907.
   PubMed Web of Science ®Google Scholar
• Simons K, Ikonen E. Functional rafts in cell membranes. Nature 1997;387:569–572.
   PubMed Web of Science ®Google Scholar
• Simons K, Gerl MJ. Revitalizing membrane rafts: new tools and insights. Nat Rev Mol Cell Biol 2010;11:688–699.
   PubMed Web of Science ®Google Scholar
• Sowa G, Pypaert M, Sessa WC. Distinction between signaling mechanisms in lipid rafts vs. caveolae. Proc Natl Acad Sci USA 2001;98:14072–14077.
   PubMed Web of Science ®Google Scholar
• Foster LJ, De Hoog CL, Mann M. Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors. Proc Natl Acad Sci USA 2003;100:5813–5818.
   PubMed Web of Science ®Google Scholar
• Lotocki G, Alonso OF, Dietrich WD, Keane RW. Tumor necrosis factor receptor 1 and its signaling intermediates are recruited to lipid rafts in the traumatized brain. J Neurosci 2004;24:11010–11016.
   PubMed Web of Science ®Google Scholar
• Allen JA, Halverson-Tamboli RA, Rasenick MM. Lipid raft microdomains and neurotransmitter signalling. Nat Rev Neurosci 2007;8:128–40.
   PubMed Web of Science ®Google Scholar
• Ostrom RS, Post SR, Insel PA. Stoichiometry and compartmentation in G protein-coupled receptor signaling: implications for therapeutic interventions involving GS. J Pharmacol Exp Ther 2000;294:407–412.
   PubMed Web of Science ®Google Scholar
• Li H, Han W, Villar VA, Keever LB, Lu Q, Hopfer U, et al. D1-like receptors regulate NADPH oxidase activity and subunit expression in lipid raft microdomains of renal proximal tubule cells. Hypertension 2009;53:1054–1061.
   PubMed Web of Science ®Google Scholar
• Zheng S, Yu P, Zeng C, Wang Z, Yang Z, Andrews PM, et al.Gα12-and Gα13-protein subunit linkage of D5 dopamine receptors in the nephron. Hypertension 2003;41:604–610.
   PubMed Web of Science ®Google Scholar
• Yu P, Asico LD, Luo Y, Andrews P, Eisner GM, Hopfer U, et al. D1 dopamine receptor hyperphosphorylation in renal proximal tubules in hypertension. Kidney Int 2006;70: 1072–1079.
   PubMed Web of Science ®Google Scholar
• Wang X, Luo Y, Escano CS, Yang Z, Asico L, Li H, et al. Upregulation of renal sodium transporters in D5 dopamine receptor-deficient mice. Hypertension 2010;55: 1431–1437.
   PubMed Web of Science ®Google Scholar
• Yu P, Yang Z, Jones JE, Wang Z, Owens SA, Mueller SC, et al. D1 dopamine receptor signaling involves caveolin-2 in HEK-293 cells. Kidney Int 2004;66:2167–2180.
   PubMed Web of Science ®Google Scholar
• Yang Z, Asico LD, Yu P, Wang Z, Jones JE, Bai RK, et al. D5 dopamine receptor regulation of phospholipase D. Am J Physiol Heart Circ Physiol 2005;288:H55–61.
   PubMed Web of Science ®Google Scholar
• Yang Z, Asico LD, Yu P, Wang Z, Jones JE, Escano CS, et al. D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure. Am J Physiol Regul Integr Comp Physiol 2006;290:R96–R104.
   PubMed Web of Science ®Google Scholar
• Felder RA, Sanada H, Xu J, Yu P, Wang Z, Watanabe H, et al. G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci USA 2002;99: 3872–3877.
   PubMed Web of Science ®Google Scholar
• Watanabe H, Xu J, Bengra C, Jose PA, Felder RA. Desensitization of human renal D1 dopamine receptors by G protein-coupled receptor kinase 4. Kidney Int 2002;62:790–798.
   PubMed Web of Science ®Google Scholar
• Song KS, Li Shengwen, Okamoto T, Quilliam LA, Sargiacomo M, Lisanti MP. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains. J Biol Chem 1996;271: 9690–9697.
   PubMed Web of Science ®Google Scholar
• Lu Q, Yang Y, Villar VA, Asico L, Jones JE, Yu P, et al. D5 dopamine receptor decreases NADPH oxidase, reactive oxygen species and blood pressure via heme oxygenase-1. Hypertens Res 2013;36:684–690.
   PubMed Web of Science ®Google Scholar
• Yu P, Asico LD, Eisner GM, Hopfer U, Felder RA, Jose PA. Renal protein phosphatase 2A activity and spontaneous hypertension in rats. Hypertension 2000;36:1053–1058.
   PubMed Web of Science ®Google Scholar
• Yu P, Han W, Villar VA, Li H, Arnaldo FB, Concepcion GP, et al. Dopamine D1 receptor-mediated inhibition of NADPH oxidase activity in human kidney cells occurs via protein kinase A-protein kinase C cross talk. Free Radic Biol Med 2011;50:832–840.
   PubMed Web of Science ®Google Scholar
• Dodd-O JM, Pearse DB. Effect of the NADPH oxidase inhibitor apocynin on ischemia-reperfusion lung injury. Am J Physiol Heart Circ Physiol 2000;279:H303–H312.
   PubMed Web of Science ®Google Scholar
• Yu P, Villar VA, Jose PA. Methods for the study of dopamine receptors within lipid rafts of kidney cells. Methods Mol Biol 2013;964:15–24.
   PubMedGoogle Scholar
• Armando I, Wang X, Villar VA, Jones JE, Asico LD, Escano C, Jose PA. Reactive oxygen species-dependent hypertension in dopamine D2 receptor-deficient mice. Hypertension 2007;49:672–678.
   PubMed Web of Science ®Google Scholar